Since then, research mainly focused on addressing the CCK-2R for imaging and therapy of MTC, a cancer type for which, only limited therapeutic options (e.g., tyrosine kinase inhibitors) are available apart from surgery. This evidence concerns the gene CCKBR and cancer.